[Use of plasma substitutes in volume substitution].
D001810:Blood Volume; D002056:Burns / Q000628:therapy; D003102:Colloids / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004573:Electrolytes / Q000627:therapeutic use; D004912:Erythrocytes; D005780:Gelatin / Q000627:therapeutic use; D006400:Hematocrit; D006801:Humans; D006982:Hypertonic Solutions / Q000627:therapeutic use; D010100:Oxygen / Q000378:metabolism; D010952:Plasma Substitutes / Q000627:therapeutic use*; D012709:Serum Albumin / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy*; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D012774:Shock, Traumatic / Q000188:drug therapy
D003102:Colloids; D003911:Dextrans; D004573:Electrolytes; D006982:Hypertonic Solutions; D010952:Plasma Substitutes; D012709:Serum Albumin; D005780:Gelatin; D010100:Oxygen
Einsatz von Plasmaersatzstoffen zur Vomumensubstitution.